BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8762731)

  • 1. Growth hormone responses to growth hormone-releasing hormone and clonidine in patients with type I diabetes and in normal controls: effect of age, body mass index and sex.
    Jacobs ML; Nathoe HM; Blankestijn PJ; Stijnen T; Weber RF
    Clin Endocrinol (Oxf); 1996 May; 44(5):547-53. PubMed ID: 8762731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
    Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
    Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone in type I diabetic and healthy man.
    Schaper NC
    Acta Endocrinol (Copenh); 1990; 122 Suppl 2():1-47. PubMed ID: 2110412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone response to growth hormone-releasing hormone and clonidine in depression.
    Gann H; Riemann D; Stoll S; Berger M; Müller WE
    Biol Psychiatry; 1995 Sep; 38(5):325-9. PubMed ID: 7495927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone responses to growth hormone-releasing hormone, clonidine and insulin-induced hypoglycemia in normal weight bulimic women.
    Coiro V; Capretti L; Volpi R; d'Amato L; Marchesi C; De Ferri A; Rossi G; Bianconi L; Marcato A; Chiodera P
    Neuropsychobiology; 1990; 23(1):8-14. PubMed ID: 2126361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 2-adrenoceptor sensitivity in anorexia nervosa: GH response to clonidine or GHRH stimulation.
    Brambilla F; Ferrari E; Cavagnini F; Invitti C; Zanoboni A; Massironi R; Catalano M; Cocchi D; Müller EE
    Biol Psychiatry; 1989 Feb; 25(3):256-64. PubMed ID: 2536561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion.
    Muller AF; Janssen JA; Lamberts SW; Bidlingmaier M; Strasburger CJ; Hofland L; van der Lely AJ
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):461-7. PubMed ID: 11678828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone (GH) responses to GH-releasing hormone in depression: correlation with GH release following clonidine.
    Lesch KP; Laux G; Erb A; Pfüller H; Beckmann H
    Psychiatry Res; 1988 Sep; 25(3):301-10. PubMed ID: 3141943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of clonidine and growth-hormone-releasing hormone on growth hormone secretion in patients with hyperthyroidism.
    Giustina A; Buffoli MG; Bussi AR; Wehrenberg WB
    Horm Res; 1991; 36(5-6):192-5. PubMed ID: 1823078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.
    Vittone J; Blackman MR; Busby-Whitehead J; Tsiao C; Stewart KJ; Tobin J; Stevens T; Bellantoni MF; Rogers MA; Baumann G; Roth J; Harman SM; Spencer RG
    Metabolism; 1997 Jan; 46(1):89-96. PubMed ID: 9005976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth parameters, growth hormone (GH) response to clonidine and circulating insulin-like growth factor-I (IGF-I), free thyroxine (FT4) and cortisol concentrations in relation to glycaemic control in children with insulin-dependent diabetes mellitus.
    Soliman AT; Ahmed HI; Asfour MG
    J Trop Pediatr; 1996 Aug; 42(4):228-32. PubMed ID: 8816035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
    Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
    Tapanainen P; Knip M; Lautala P; Leppäluoto J
    J Clin Endocrinol Metab; 1988 Oct; 67(4):845-9. PubMed ID: 3138280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced growth hormone responses to growth hormone releasing hormone in male type I diabetic patients.
    Pietschmann P; Schernthaner G; Stephenson J; Lang I; Templ H
    Horm Metab Res; 1991 Aug; 23(8):379-82. PubMed ID: 1794841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH) response to GH-releasing peptide-6 in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion.
    Catalina PF; Mallo F; Andrade MA; García-Mayor RV; Diéguez C
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3663-7. PubMed ID: 9768681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low circulating IGF-I levels in hyperthyroidism are associated with decreased GH response to GH-releasing hormone.
    Ramos-Dias JC; Yateman M; Camacho-Hübner C; Grossman A; Lengyel AM
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):583-9. PubMed ID: 8548943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
    Procopio M; Maccario M; Grottoli S; Oleandri SE; Boffano GM; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
    Hoeck HC; Vestergaard P; Jakobsen PE; Falhof J; Laurberg P
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1467-72. PubMed ID: 10770183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity.
    Maccario M; Tassone F; Gianotti L; Lanfranco F; Grottoli S; Arvat E; Muller EE; Ghigo E
    J Clin Endocrinol Metab; 2001 Jan; 86(1):167-71. PubMed ID: 11231996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.